Objective: To describe a series of patients with bilateral acute iris transillumination, pigment dispersion, and sphincter paralysis. Methods: We reviewed the medical records and clinical photographs of 26 patients seen at 5 centers in Turkey and Belgium between March 16, 2006, and July 6, 2010. Observation procedures included clinical examination, anterior segment color photography, gonioscopy, laser flare photometry, and pupillometry. Results: All 26 patients (20 women and 6 men; mean [SD] age, 43.2 [10.5] years) had bilateral involvement. Twenty-three patients (88%) had acute-onset disease with severe photophobia and red eyes. Nineteen patients (73%) had a preceding flulike illness and used systemic antibiotics, including moxifloxacin. D...
Background Bilateral Acute Depigmentation of the Iris (BADI) is a condition which wa...
Purpose: To report new cases of bilateral acute depigmentation of the iris (BADI), a recently descri...
OBJECTIVE: To report a newly recognized adverse effect of oral moxifloxacin. DESIGN: Observational c...
Objective: To describe a series of patients with bilateral acute iris transillumination, pigment dis...
Objective: To describe a series of patients with bilateral acute iris transillumination, pigment dis...
WOS: 000383720500009PubMed ID: 27330389Bilateral acute iris transillumination (BAIT) is a recently d...
AbstractBilateral acute iris transillumination (BAIT) is a recently defined disease characterized wi...
Bilateral acute iris transillumination (BAIT) is a relatively new clinical entity characterized by b...
Bilateral acute depigmentation of the iris (BADI) is a recently described entity characterized by ac...
Bilateral Acute Iris Transillumination (BAIT) is a new clinical entity characterized by acute onset ...
Purpose: To report the first simultaneous onset of bilateral acute depigmentation of the iris (BADI)...
Bilateral acute depigmentation of the iris (BADI) usually affecting young women, is a newly defined ...
A 56-year-old paramedic was admitted to hospital and treated for severe pneumonia. Shortly after ini...
Bilateral acute iris transillumination (BAIT) is a relatively new clinical entity characterized by b...
A 47-year-old male presented with bilateral 4 + circulating pigment in the anterior chamber, diffuse...
Background Bilateral Acute Depigmentation of the Iris (BADI) is a condition which wa...
Purpose: To report new cases of bilateral acute depigmentation of the iris (BADI), a recently descri...
OBJECTIVE: To report a newly recognized adverse effect of oral moxifloxacin. DESIGN: Observational c...
Objective: To describe a series of patients with bilateral acute iris transillumination, pigment dis...
Objective: To describe a series of patients with bilateral acute iris transillumination, pigment dis...
WOS: 000383720500009PubMed ID: 27330389Bilateral acute iris transillumination (BAIT) is a recently d...
AbstractBilateral acute iris transillumination (BAIT) is a recently defined disease characterized wi...
Bilateral acute iris transillumination (BAIT) is a relatively new clinical entity characterized by b...
Bilateral acute depigmentation of the iris (BADI) is a recently described entity characterized by ac...
Bilateral Acute Iris Transillumination (BAIT) is a new clinical entity characterized by acute onset ...
Purpose: To report the first simultaneous onset of bilateral acute depigmentation of the iris (BADI)...
Bilateral acute depigmentation of the iris (BADI) usually affecting young women, is a newly defined ...
A 56-year-old paramedic was admitted to hospital and treated for severe pneumonia. Shortly after ini...
Bilateral acute iris transillumination (BAIT) is a relatively new clinical entity characterized by b...
A 47-year-old male presented with bilateral 4 + circulating pigment in the anterior chamber, diffuse...
Background Bilateral Acute Depigmentation of the Iris (BADI) is a condition which wa...
Purpose: To report new cases of bilateral acute depigmentation of the iris (BADI), a recently descri...
OBJECTIVE: To report a newly recognized adverse effect of oral moxifloxacin. DESIGN: Observational c...